PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Didangelos, T.* ; Kantartzis, K.

Diabetes and heart failure: Is it hyperglycemia or hyperinsulinemia?

Curr. Vasc. Pharmacol. 18, 148-157 (2020)
Postprint DOI PMC
Open Access Green
The cardiac effects of exogenously administered insulin for the treatment of diabetes (DM) have recently attracted much attention. In particular, it has been questioned whether insulin is the appropriate treatment for patients with type 2 diabetes mellitus and heart failure. While several old and some new studies suggested that insulin treatment has beneficial effects on the heart, recent observational studies indicate associations of insulin treatment with an increased risk of developing or worsening of pre-existing heart failure and higher mortality rates. However, there is actually little evidence that the associations of insulin administration with any adverse outcomes are causal. On the other hand, insulin clearly causes weight gain and may also cause serious episodes of hypoglycemia. Moreover, excess of insulin (hyperinsulinemia), as often seen with the use of injected insulin, seems to predispose to inflammation, hypertension, dyslipidemia, atherosclerosis, heart failure, and arrhythmias. Nevertheless, it should be stressed that most of the data concerning the effects of insulin on cardiac function derive from in vitro studies with isolated animal hearts. Therefore, the relevance of the findings of such studies for humans should be considered with caution. In the present review, we summarize the existing data about the potential positive and negative effects of insulin on the heart and attempt to answer the question whether any adverse effects of insulin or the consequences of hyperglycemia are more important and may provide a better explanation of the close association of DM with heart failure.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
2.672
0.491
6
6
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Schlagwörter Diabetes ; Insulin ; Heart Failure ; Diastolic Dysfunction ; Systolic Dysfunction ; Cardiomyopathy ; Autonomic Neuropathy; Cotransporter 2 Inhibitors; Multifactorial Intervention; Cardiovascular-disease; Cardiac Efficiency; Glycemic Control; Controlled-trial; Blood-pressure; Insulin; Mellitus; Cardiomyopathy
Sprache englisch
Veröffentlichungsjahr 2020
Prepublished im Jahr 2019
HGF-Berichtsjahr 2019
ISSN (print) / ISBN 1570-1611
e-ISSN 1875-6212
Zeitschrift Current Vascular Pharmacology
Quellenangaben Band: 18, Heft: 2, Seiten: 148-157 Artikelnummer: , Supplement: ,
Verlag Bentham Science Publishers
Verlagsort San Francisco, Calif.
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes Research and Metabolic Diseases (IDM)
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-502400-001
DOI 10.2174/1570161117666190408164326
WOS ID WOS:000509755000007
PubMed ID 30963973
Erfassungsdatum 2019-05-07
[➜Korrektur melden]